期刊
BIOFACTORS
卷 47, 期 1, 页码 41-58出版社
WILEY
DOI: 10.1002/biof.1690
关键词
anti‐ inflammation; brain; ischemic stroke; melatonin; obesity
资金
- Royal Golden Jubilee PhD program [PHD/0104/2561]
- Thailand Research Fund [RSA6080025]
- Functional Food Research Center for Well-being
- Chiang Mai University
Obesity is a major risk factor for ischemic stroke and often coexists with it. The susceptibility for ischemic brain damage increases significantly with concomitant obesity, and inflammation plays a key role. Melatonin shows potential in exerting anti-inflammatory effects and providing protection against obesity and ischemic stroke, although more research is needed on its effectiveness in cases of ischemic stroke with obesity-induced inflammation.
Obesity is a predominant risk factor in ischemic stroke and is commonly comorbid with it. Pathologies following these conditions are associated with systemic and local inflammation. Moreover, there is increasing evidence that the susceptibility for ischemic brain damage increases substantially in experimental models of ischemic stroke with concomitant obesity. Herein, we explore the proinflammatory events that occur during ischemic stroke and obesity, and we discuss the influence of obesity on the inflammatory response and cerebral damage outcomes in experimental models of brain ischemia. In addition, because melatonin is a neurohormone widely reported to exhibit protective effects in various diseases, this study also demonstrates the anti-inflammatory role and possible mechanistic actions of melatonin in both epidemic diseases. A summary of research findings suggests that melatonin administration has great potential to exert an anti-inflammatory role and provide protection against obesity and ischemic stroke conditions. However, the efficacy of this hormonal treatment on ischemic stroke with concomitant obesity, when more serious inflammation is generated, is still lacking.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据